(Q43198292)

English

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

scientific article published on 11 January 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

E Willems

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

S Humblet-Baron

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

O Dengis

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

L Seidel

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Y Beguin

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

F Baron

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

0 references

publication date

11 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1442-1448

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

What is the role for donor natural killer cells after nonmyeloablative conditioning?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Inflammation and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Mixed chimerism and transplant tolerance

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Graft-versus-host disease: how to translate new insights into new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

21 January 2018

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.360

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2009.360

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43198292&oldid=2205862968"